| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 756134 | GSK1023156A | 0.0382675857669588 | 0.27223506 |
| NSC 756170 | GSK317315A | 0.0382675857669588 | 0.43560653 |
| NSC 757946 | (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.0382675857669588 | -0.27956642 |
| NSC 683326 | Null | 0.0388857481216103 | 0.48905953 |
| NSC 691424 | Null | 0.0388857481216103 | -0.024609754 |
| NSC 700893 | 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) | 0.0388857481216103 | -0.19483843 |
| NSC 756078 | 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole | 0.0388857481216103 | 0.2100462 |
| NSC 115928 | Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) | 0.0420893367628876 | 0.72542081 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0420893367628876 | 0.65388785 |
| NSC 292147 | 12-Hydroxyindolo[2,1-b]quinazoline-6(12H)-one | 0.0420893367628876 | 0.034856422 |